Stay updated on ED-SCLC Immuno-Therapy Clinical Trial
Sign up to get notified when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.

Latest updates to the ED-SCLC Immuno-Therapy Clinical Trial page
- Check2 days agoChange DetectedThe page footer now shows an updated system/version label (“Revision: v3.5.3”). Related topic text in the surrounding MedlinePlus/links area was adjusted, without changing the study’s core details.SummaryDifference0.1%

- Check9 days agoChange DetectedOno Pharmaceutical Co., Ltd. was added as a collaborator; revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check16 days agoChange DetectedAdded related topics such as Lung cancer and MedlinePlus Genetics to the page.SummaryDifference0.1%

- Check24 days agoChange DetectedLung cancer, related topics, and MedlinePlus Genetics links were removed from the page.SummaryDifference0.1%

- Check31 days agoChange DetectedLung cancer and related topics, including MedlinePlus Genetics, were added to the page.SummaryDifference0.1%

- Check38 days agoChange Detected- Added Revision: v3.5.0. - Removed Lung cancer and MedlinePlus Genetics related topics and Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to ED-SCLC Immuno-Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.